Summary DiaGenic ASA (DiaGenic) is a medical company that creates value for patients, partners and investors by developing innovative and patient friendly in vitro diagnostic products for early detection of diseases. The company specializes in developing blood-based biomarkers. Its ADtect product is a blood test that helps distinguish mild to moderate range AD from the absence of dementia. DiaGenic also has IP position, unique access to biobanks and mature technology in late stage development of products for commercialization in major markets. The company's tests are based on the observation that a focal lesion or disorder gives rise to a systemic response which can be measured in the blood. DiaGenic is headquartered in Oslo, Norway. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company DiaGenic ASA - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 DiaGenic ASA Company Snapshot 6 DiaGenic ASA Company Overview 6 DiaGenic ASA Pipeline Products and Clinical Trials Overview 7 DiaGenic ASA - Pipeline Analysis Overview 9 Key Facts 9 DiaGenic ASA - Major Products and Services 10 DiaGenic ASA Pipeline Products by Development Stage 11 DiaGenic ASA Pipeline Products Overview 13 ADtect PLUS 13 ADtect PLUS Product Overview 13 ADtect ULTRA 14 ADtect ULTRA Product Overview 14 AMYtect 15 AMYtect Product Overview 15 MCItect - New Version 16 MCItect - New Version Product Overview 16 MCItect PLUS 17 MCItect PLUS Product Overview 17 MCItect ULTRA 18 MCItect ULTRA Product Overview 18 New ADtect 19 New ADtect Product Overview 19 PDtect 20 PDtect Product Overview 20 DiaGenic ASA - Key Competitors 21 DiaGenic ASA - Key Employees 22 DiaGenic ASA - Locations And Subsidiaries 23 Head Office 23 Recent Developments 24 DiaGenic ASA, Recent Developments 24 Aug 21, 2014: DiaGenic Announces Q2 2014 Financial Report 24 Mar 20, 2014: DiaGenic Appoints New CEO 24 Feb 20, 2014: DiaGenic: Report from Fourth Quarter 2013 24 Jan 31, 2014: DiaGenic: New CEO and New Company Address 25 Jan 23, 2014: DiaGenic reports AMYtect study results 25 Nov 22, 2013: Extraordinary General Meeting held in DiaGenic 26 Nov 22, 2013: Extraordinary general meeting held in DiaGenic ASA 26 Nov 13, 2013: DiaGenic ASA: Report from third quarter 2013 26 Nov 11, 2013: DiaGenic To Present results for third quarter 2013 27 Oct 29, 2013: DiaGenic provides update on AMYtect study 27 Appendix 28 Methodology 28 About GlobalData 28 Contact Us 28 Disclaimer 28
List of Tables
DiaGenic ASA Pipeline Products and Clinical Trials Overview 7 DiaGenic ASA Pipeline Products by Equipment Type 7 DiaGenic ASA Pipeline Products by Indication 8 DiaGenic ASA, Key Facts 9 DiaGenic ASA, Major Products and Services 10 DiaGenic ASA Number of Pipeline Products by Development Stage 11 DiaGenic ASA Pipeline Products Summary by Development Stage 12 ADtect PLUS - Product Status 13 ADtect PLUS - Product Description 13 ADtect ULTRA - Product Status 14 ADtect ULTRA - Product Description 14 AMYtect - Product Status 15 AMYtect - Product Description 15 MCItect - New Version - Product Status 16 MCItect - New Version - Product Description 16 MCItect PLUS - Product Status 17 MCItect PLUS - Product Description 17 MCItect ULTRA - Product Status 18 MCItect ULTRA - Product Description 18 New ADtect - Product Status 19 New ADtect - Product Description 19 PDtect - Product Status 20 PDtect - Product Description 20 DiaGenic ASA, Key Employees 22
List of Figures
DiaGenic ASA Pipeline Products by Equipment Type 8 DiaGenic ASA Pipeline Products by Development Stage 11
Global 3D scanning market is expected to be valued at USD 4,900.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing need for speedy and precise results with high efficiency is anticipated to drive the industry. 3DRead More...
Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to moRead More...
Global glycerol market size is likely to exceed USD 3 billion by 2022, as per a new research report by Radiant Insights, Inc. Regulatory push for promoting bio-diesel production is expected to boost glycerol demand over the forecast period, with expeRead More...
Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population iRead More...
Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecastRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.